Merck is looking to sell certain animal-health assets to avoid antitrust problems with its $41 billion acquisition of Schering-Plough.
WSJ.com: US Business, Wall Street Journal: Business
Wed, 06/03/2009 - 11:05am
Merck is looking to sell certain animal-health assets to avoid antitrust problems with its $41 billion acquisition of Schering-Plough.